Climb Financial Statements From 2010 to 2025
| CLYM Stock | | | 1.69 0.06 3.68% |
Climb Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Climb Bio's valuation are provided below:
Market Capitalization | Earnings Share |
There are over ninety available fundamental signals for Climb Bio, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to validate Climb Bio's prevailing
fundamentals against the trend between
2010 and 2025 to make sure the company can sustain itself down the road. As of the 14th of August 2025,
Market Cap is likely to grow to about 104.4
M, though
Enterprise Value is likely to grow to (2.9
K).
Check out the analysis of
Climb Bio Correlation against competitors.
To learn how to invest in Climb Stock, please use our
How to Invest in Climb Bio guide.
Climb Bio Balance Sheet | | |
|
Climb Bio Income Statement | | |
|
Climb Bio Cash Flow Statement | | |
|
Financial Ratios | | |
|
Climb Bio Valuation Data | | |
| Current Value | Last Year | Historical Average | 10 Year Trend |
|---|
| Market Cap | 104.4 M | 86.7 M | 106.8 M | |
|
Climb Fundamental Market Drivers
| Cash And Short Term Investments | 150.9 M |
About Climb Bio Financial Statements
Climb Bio investors utilize fundamental indicators, such as revenue or net income, to predict how Climb Stock might perform in the future. Analyzing these trends over time helps investors make informed
market timing decisions. For further insights, please visit our
fundamental analysis page.
| | Last Reported | Projected for Next Year |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetWhen determining whether Climb Bio is a strong investment it is important to analyze Climb Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Climb Bio's
future performance.
For an informed investment choice regarding Climb Stock, refer to the following important reports: Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost
the valuation of Climb Bio. If investors know Climb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Climb Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share | Return On Assets | Return On Equity |
The market value of Climb Bio is measured differently than its book value, which is the value of Climb that is recorded on the company's balance sheet. Investors also form their own opinion of Climb Bio's value that differs from its market value or its book value, called intrinsic value, which is Climb Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Climb Bio's market value can be influenced by many factors that don't directly affect Climb Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Climb Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine
if Climb Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Climb Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.